TORONTO and KINGSTON, Jamaica, Feb. 10, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc., through its wholly-owned subsidiary Psyence Therapeutics Corp. (“ Psyence”), is pleased to announce it has entered into a Research Collaboration Agreement with MycoMeditations Inc (“MycoMeditations”), a leading psilocybin retreat provider to conduct an observational study of the efficacy of naturally derived…


Previous articleNew Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Next articleFeb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%